FDA offers guidance on financial disclosures under Sunshine Act

03/7/2013 | MassDevice.com (Boston)

The FDA has issued draft guidance governing financial disclosures mandated by the Sunshine Act, which will go into effect Aug. 1. The document explains how manufacturers should report financial ties with doctors when applying for FDA marketing approval, which of those relationships should be reported and how bias is established.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR